Thus, theobjective of our present study is to systematically explore the renal protective effects of marein SYFSF on DKD and for the first time to focus on revealing whether HIF-1 mediated metabolic reprogramming contributes to its therapeutic potential. Here, HIF1A is linked to diabetic kidney disease.